Evidence brief · Supplement

Strontium for Fracture (ranelate, Rx)

Evidence grade B — But CV risk

Overall grade
Grade B
Last revised
1
graded outcome
0
references listed

Assembled by the app from other entries in this library. It adds no evidence of its own — follow the links to the entries it draws on.

1 at grade B — 1 graded row

What is known

Each outcome with its grade (how strong the evidence is, A to D), the size of the effect where the entry records one, and how often studies agree.

  • Fracture (ranelate, Rx)Evidence grade B

    But CV risk

    Moderatehigh

The evidence in words

The verdict

For fracture (ranelate, rx), Strontium earns evidence grade B (moderate effect, high consistency) — there is real evidence here. But CV risk

How it might work

It incorporates into bone and appears to both increase formation and reduce resorption; it also inflates DXA bone-density readings (a measurement artifact).

How to use it

Safety & cautions

Cardiovascular-risk signal (from the ranelate data); interferes with calcium absorption and DXA interpretation.

Bottom line

The effective form carried cardiovascular risk and was restricted; the supplement form is unproven and confounds bone scans. Not a first-line bone choice.

Goes with

  • StrontiumRead the full Strontium monographEvidence grade C

Entries that share this one's tags or conditions.

Sources

This entry lists no references of its own — it is assembled from the entries it links to, whose sources are on their pages.

Last revised . A grade is this entry's reading of the evidence, not medical advice.